Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0105 Transporter Info
Gene Name	SLC16A14
Transporter Name	Monocarboxylate transporter 14
Gene ID	151473
UniProt ID	Q7RTX9

Post-Translational Modification of This DT
Overview of SLC16A14 Modification Sites with Functional and Structural Information
Sequence	M Y T S H E D I G Y D F E D G P K D K K T L K P H P N I D G G W A W M M V L S S F F V H I L I M G S Q M A L G V L N V E W L E E F H Q S R G L T A W V S S L S M G I T L I V G P F I G L F I N T C G C R Q T A I I G G L V N S L G W V L S A Y A A N V H Y L F I T F G V A A G L G S G M A Y L P A V V M V G R Y F Q K R R A L A Q G L S T T G T G F G T F L M T V L L K Y L C A E Y G W R N A M L I Q G A V S L N L C V C G A L M R P L S P G K N P N D P G E K D V R G L P A H S T E S V K S T G Q Q G R T E E K D G G L G N E E T L C D L Q A Q E C P D Q A G H R K N M C A L R I L K T V S W L T M R V R K G F E D W Y S G Y F G T A S L F T N R M F V A F I F W A L F A Y S S F V I P F I H L P E I V N L Y N L S E Q N D V F P L T S I I A I V H I F G K V I L G V I A D L P C I S V W N V F L L A N F T L V L S I F I L P L M H T Y A G L A V I C A L I G F S S G Y F S L M P V V T E D L V G I E H L A N A Y G I I I C A N G I S A L L G P P F A G W I Y D I T Q K Y D F S F Y I C G L L Y M I G I L F L L I Q P C I R I I E Q S R R K Y M D G A H V
PTM type	X-Phosphorylation X: Amino Acid

Phosphorylation
Serine	5 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC16A14			[1] , [2]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	4
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC16A14 Serine 4 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC16A14			[3]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	213
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC16A14 Serine 213 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC16A14			[2] , [4]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	233
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC16A14 Serine 233 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC16A14			[5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	236
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC16A14 Serine 236 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC16A14			[6]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	419
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC16A14 Serine 419 has the potential to affect its expression or activity.
Threonine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC16A14			[1] , [2]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	3
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC16A14 Threonine 3 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC16A14			[2]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	234
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC16A14 Threonine 234 has the potential to affect its expression or activity.
Tyrosine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC16A14			[1] , [2]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	2
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC16A14 Tyrosine 2 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC16A14			[7]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	10
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC16A14 Tyrosine 10 has the potential to affect its expression or activity.

References
1	Proteogenomic integration reveals therapeutic targets in breast cancer xenografts. Nat Commun. 2017 Mar 28;8:14864.
2	Phosphoproteomic screening identifies Rab GTPases as novel downstream targets of PINK1. EMBO J. 2015 Nov 12;34(22):2840-61.
3	Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
4	Quantitative phosphoproteomic analysis reveals system-wide signaling pathways regulated by site-specific phosphorylation of Keratin-8 in skin squamous cell carcinoma derived cell line. Proteomics. 2017 Apr;17(7).
5	Comprehensive quantitative comparison of the membrane proteome, phosphoproteome, and sialiome of human embryonic and neural stem cells. Mol Cell Proteomics. 2014 Jan;13(1):311-28.
6	Identification of phosphopeptides with unknown cleavage specificity by a de novo sequencing assisted database search strategy. Proteomics. 2014 Nov;14(21-22):2410-6.
7	Neuroblastoma tyrosine kinase signaling networks involve FYN and LYN in endosomes and lipid rafts. PLoS Comput Biol. 2015 Apr 17;11(4):e1004130.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence